Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 29-34

  Allan, Donald R ^a   Penner, S Brian ^a   Smyth, Donald D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Clonidine; Imidazoline receptor; Moxonidine; 2 adrenoceptor

Indexed keywords

DIURETIC AGENT; IDAZOXAN; IMIDAZOLINE RECEPTOR; MOXONIDINE; RECEPTOR BLOCKING AGENT; SODIUM ION;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURETIC ACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NONHUMAN; OSMOTIC DIURESIS; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINE FLOW RATE;

EID: 0030052614     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15150.x     Document Type: Article

References (29)

1. ALLAN, D.R., PENNER, S.B. & SMYTH, D.D. (1993). Renal imidazoline preferring sites and solute excretion in the rat. Br. J. Pharmacol., 108, 870-876.
2. + transport and intracellular pH in renal proximal tubule cells. Biochim. Biophys. Acta, 1024, 173-178.
3. BLANDFORD, D.E. & SMYTH, D.D. (1988a). Dose selective dissociation of water and solute excretion after alpha-2 adrenoceptor stimulation. J. Pharmacol. Exp. Ther., 247, 1181-1186.
4. 2 adrenoceptor blockade decreases sodium and water excretion in the anesthetized rat. Eur. J. Pharmacol., 154, 117-124.
5. 2-adrenoceptor agonists. J. Pharmacol. Exp. Ther., 255, 264-270.
6. 3H]idazoxan in rat brain. J. Pharmacol. Exp. Ther., 241, 1079-1091.
7. BRICCA, G., DONTENWILL, M., MOLINES, A., FELDMAN, J., BELCOURT, A. & BOUSQUET, P. (1989). The imidazoline preferring receptor: Binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol., 162, 1-9.
8. COUPRY, I., PODEVIN, R.A., DAUSSE, J.P. & PARINI, A. (1987). Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem. Biophys. Res. Commun., 147, 1055-1060.
9. DABIRE, H. (1986). Idazoxan: a novel pharmacological tool for the study of alpha-2 adrenoceptors. J. Pharmacol., 17, 113-118.
10. 1-imidazoline sites. J. Pharmacol. Exp. Ther., 264, 172-182.
11. ERNSBERGER, P., FEINLAND, G., MEELEY, M.P. & REIS, D.J. (1990). Characterization and visualization of clonidine-sensitive imidazoline sites in rat kidney which recognize clonidine-displacing substances. Am. J. Hypertens., 3, 90-97.
12. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20 (Suppl. 4), S1-S10.
13. FELDMAN, J., TIBIRICA, E., BRICCA, G., DONTENWILL, M., BELCOURT, A. & BOUSQUET, P. (1990). Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol., 100, 600-604.
14. FREEDMAN, J.E. & AGHAJANIAN, G.K. (1984). Idazoxan (RX 781094) selectively antagonizes alpha-2 adrenoceptors on rat central neurons. Eur. J. Pharmacol., 105, 265-272.
15. 2 adrenoceptors. Am. J. Physiol., 28, F1-F8.
16. 2-agonist and antagonist properties of RX 781094. Eur. J. Pharmacol., 91, 101-105.
17. GOMEZ, R.E., ERNSBERGER, P., FEINLAND, U. & RElS, D.J. (1991). Rilmenidme lowers arterial blood pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol., 195, 181-191.
18. LEHMANN, J., KEONIG-BERARD, E. & VITOU, P. (1989). The imidazoline preferring receptor. Life Sci., 45, 1609-1615.
19. LI, G., REGUNTHAN, S., BARROW, C., ESHRAGHI, J., COOPER, R. & REIS, D. (1994). Agmatine: An endogenous clonidine-displacing substance in the brain. Science, 263, 966-969.
20. 3H]Idazoxan and some other alpha-2 adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol. Pharmacol., 35, 324 330.
21. MICHEL, M.C. & ERNSBERGER, P. (1992). Keep an eye on the I-site: Imidazoline preferring receptors. Trends Pharmacol. Sci., 13, 369-370.
22. 3H] idazoxan binding sites are physically distinct from alpha-2 adrenergic receptors. Mol. Pharmacol., 37, 65-68.
23. PACIOREK, P.M. & SHEPPERSON, N.B. (1983). Alpha-1 adrenoceptor agonist activity of alpha-2 adrenoceptor antagonists in the pithed rat preparation. Br. J. Pharmacol., 95, 12-14.
24. REIS, D.J., REGUNTHAN, S., WANG, H., FEINSTEIN, D.L. & MEELEY, M.P (1992). Imidazoline receptors in the nervous system. Fundam. Clin. Pharmacol., 6 (Suppl. 1), 23S-29S.
25. SCHWIETERT, R.D., WILHELM, D., WILFFERT, B & VAN ZWIETEN, P.A. (1992). The effect of some alpha-adrenoceptor antagonists on spontaneous myogenic activity in the rat portal vein and the putative involvement of ATP-sensitive potassium channels. Eur. J. Pharmacol., 211, 87-95.
26. 1 adrenoceptor antagonism of vasopressin. Circ. Res., 57, 304-311.
27. TIBIRICA, E., FELDMAN, J., MERMET, C., GONON, F. & BOUSQUET, P. (1991). An imidazoline-specific mechanism for the hypotensive effect of clonidine, A study with yohimbine and idazoxan. J. Pharmacol. Exp. Ther., 256, 606-613.
28. TIMMERMANS, P.B.M.W.M., QIAN, J.Q., RLIFFOLO, R.R. JR. & VAN ZWIETEN, P.A. (1984). A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors. J. Pharmacol. Exp. Ther., 228, 739-748.
29. WINER, B.J. (1971). Statistical Principles in Experimental Designs. 2nd Edition. New York: McGraw-Hill.